|
|
|
A conversation with Elena Koundourakis, head of the Orexin Franchise Development and Neuroscience Portfolio Strategy, Takeda | Takeda Head of the Orexin Franchise Development and Neuroscience Portfolio Strategy Elena Koundourakis explains why her team decided to pursue the use of DHTs and the benefits of doing so, for both the patients and the data accuracy. |
|
|
|
|
| Machine Learning To Drive Clinical Trial Efficiency | White Paper | Revvity Signals Software, Inc. | Read on as authors explore accessing real-time clinical trial data for proactive study management, using adverse event data to enhance safety and performance, and tools to improve design. |
|
|
| A Strategic Framework For Positive Site-Sponsor Relationships | Article | By Matthew Jones and Julia Scanlon, IQVIA Technologies | Through an examination of evolving trial strategies and implementation, we aim to lay the groundwork for a collaborative, mutually beneficial atmosphere, ultimately leading to a sustainable competitive edge. |
|
|
|
|
.png){kind=logo}
